DK0944612T3 - N-(4-Acetyl-1-piperazinyl)-4-fluorbenzamidhydrat - Google Patents
N-(4-Acetyl-1-piperazinyl)-4-fluorbenzamidhydratInfo
- Publication number
- DK0944612T3 DK0944612T3 DK97946110T DK97946110T DK0944612T3 DK 0944612 T3 DK0944612 T3 DK 0944612T3 DK 97946110 T DK97946110 T DK 97946110T DK 97946110 T DK97946110 T DK 97946110T DK 0944612 T3 DK0944612 T3 DK 0944612T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- piperazinyl
- acetyl
- date jun
- sec
- Prior art date
Links
- -1 4-acetyl-1-piperazinyl Chemical group 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XTOKQKWTUYYVAO-UHFFFAOYSA-N n-(4-acetylpiperazin-1-yl)-4-fluorobenzamide Chemical compound C1CN(C(=O)C)CCN1NC(=O)C1=CC=C(F)C=C1 XTOKQKWTUYYVAO-UHFFFAOYSA-N 0.000 abstract 1
- YCRCWHFFTTVANS-UHFFFAOYSA-N n-(4-acetylpiperazin-1-yl)-4-fluorobenzamide;hydrate Chemical compound O.C1CN(C(=O)C)CCN1NC(=O)C1=CC=C(F)C=C1 YCRCWHFFTTVANS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33178496 | 1996-12-12 | ||
| PCT/JP1997/004451 WO1998025914A1 (en) | 1996-12-12 | 1997-12-05 | N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0944612T3 true DK0944612T3 (da) | 2001-11-19 |
Family
ID=18247607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97946110T DK0944612T3 (da) | 1996-12-12 | 1997-12-05 | N-(4-Acetyl-1-piperazinyl)-4-fluorbenzamidhydrat |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6147079A (da) |
| EP (1) | EP0944612B1 (da) |
| JP (1) | JP3254683B2 (da) |
| KR (1) | KR20000057342A (da) |
| CN (1) | CN1073104C (da) |
| AT (1) | ATE205198T1 (da) |
| AU (1) | AU722095B2 (da) |
| CA (1) | CA2274682A1 (da) |
| DE (1) | DE69706562T2 (da) |
| DK (1) | DK0944612T3 (da) |
| EA (1) | EA001715B1 (da) |
| ES (1) | ES2160371T3 (da) |
| GR (1) | GR3036542T3 (da) |
| HU (1) | HUP0002975A3 (da) |
| IL (1) | IL130273A (da) |
| PT (1) | PT944612E (da) |
| TW (1) | TW422844B (da) |
| WO (1) | WO1998025914A1 (da) |
| ZA (1) | ZA9710872B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9812736A (pt) * | 1997-10-09 | 2000-08-22 | Fujisawa Pharmaceutical Co | Novo processo para produzir derivados de aminopiperazina |
| AUPP818099A0 (en) * | 1999-01-14 | 1999-02-11 | Fujisawa Pharmaceutical Co., Ltd. | New n-containing heterocyclic compounds |
| US6344358B1 (en) | 1999-05-28 | 2002-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| GB0021885D0 (en) * | 2000-09-06 | 2000-10-18 | Fujisawa Pharmaceutical Co | New use |
| JPWO2002034735A1 (ja) * | 2000-10-23 | 2004-03-04 | 藤沢薬品工業株式会社 | 溶媒和物の取得方法及び溶媒和物 |
| CA2431181A1 (en) * | 2000-12-07 | 2002-06-13 | Nobuya Matsuoka | Nootropic effect enhancer |
| AU2003227473A1 (en) * | 2002-04-10 | 2003-10-20 | Fujisawa Pharmaceutical Co., Ltd. | Neurotrophic factor production accelerator |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917687D0 (en) * | 1989-08-02 | 1989-09-20 | Fujisawa Pharmaceutical Co | Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| US5250528A (en) * | 1989-08-02 | 1993-10-05 | Fujisawa Pharmaceutical Co., Ltd. | New aminopiperazine derivatives |
-
1997
- 1997-12-03 ZA ZA9710872A patent/ZA9710872B/xx unknown
- 1997-12-05 WO PCT/JP1997/004451 patent/WO1998025914A1/en not_active Application Discontinuation
- 1997-12-05 AU AU51368/98A patent/AU722095B2/en not_active Ceased
- 1997-12-05 PT PT97946110T patent/PT944612E/pt unknown
- 1997-12-05 HU HU0002975A patent/HUP0002975A3/hu unknown
- 1997-12-05 EA EA199900530A patent/EA001715B1/ru not_active IP Right Cessation
- 1997-12-05 DK DK97946110T patent/DK0944612T3/da active
- 1997-12-05 US US09/319,271 patent/US6147079A/en not_active Expired - Fee Related
- 1997-12-05 ES ES97946110T patent/ES2160371T3/es not_active Expired - Lifetime
- 1997-12-05 DE DE69706562T patent/DE69706562T2/de not_active Expired - Fee Related
- 1997-12-05 CA CA002274682A patent/CA2274682A1/en not_active Abandoned
- 1997-12-05 CN CN97181731A patent/CN1073104C/zh not_active Expired - Fee Related
- 1997-12-05 IL IL13027397A patent/IL130273A/xx not_active IP Right Cessation
- 1997-12-05 KR KR1019990704843A patent/KR20000057342A/ko not_active Ceased
- 1997-12-05 AT AT97946110T patent/ATE205198T1/de not_active IP Right Cessation
- 1997-12-05 EP EP97946110A patent/EP0944612B1/en not_active Expired - Lifetime
- 1997-12-05 JP JP50681698A patent/JP3254683B2/ja not_active Expired - Fee Related
- 1997-12-11 TW TW086118669A patent/TW422844B/zh not_active IP Right Cessation
-
2001
- 2001-09-06 GR GR20010401324T patent/GR3036542T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998025914A1 (en) | 1998-06-18 |
| DE69706562T2 (de) | 2002-05-29 |
| JP3254683B2 (ja) | 2002-02-12 |
| KR20000057342A (ko) | 2000-09-15 |
| DE69706562D1 (de) | 2001-10-11 |
| GR3036542T3 (en) | 2001-12-31 |
| EP0944612B1 (en) | 2001-09-05 |
| ES2160371T3 (es) | 2001-11-01 |
| PT944612E (pt) | 2002-01-30 |
| TW422844B (en) | 2001-02-21 |
| CN1073104C (zh) | 2001-10-17 |
| EA199900530A1 (ru) | 1999-12-29 |
| JP2000514460A (ja) | 2000-10-31 |
| AU722095B2 (en) | 2000-07-20 |
| HUP0002975A3 (en) | 2002-01-28 |
| EP0944612A1 (en) | 1999-09-29 |
| ZA9710872B (en) | 1998-06-15 |
| EA001715B1 (ru) | 2001-08-27 |
| IL130273A0 (en) | 2000-06-01 |
| IL130273A (en) | 2003-05-29 |
| ATE205198T1 (de) | 2001-09-15 |
| US6147079A (en) | 2000-11-14 |
| HK1024482A1 (en) | 2000-10-13 |
| CA2274682A1 (en) | 1998-06-18 |
| AU5136898A (en) | 1998-07-03 |
| CN1245495A (zh) | 2000-02-23 |
| HUP0002975A2 (hu) | 2001-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69531457D1 (en) | Sulfonamide | |
| SE9604793L (sv) | Nya Kristallmodifikationer | |
| ATE262895T1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| GB9406857D0 (en) | Improvements in or relating to organic compounds | |
| DE59508891D1 (de) | Hautpflegemittel | |
| IL116231A (en) | Dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals as thrombin inhibitors | |
| DE69311541D1 (de) | Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten | |
| IL122894A0 (en) | Fungicidal mixtures | |
| DE69706562D1 (de) | N-(4-acetyl-1-piperazinyl)-4-fluorobenzamidhydrat | |
| DE69535263D1 (de) | Angiotensin ii zur verbesserung der befruchtung | |
| ATE200624T1 (de) | Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis | |
| DE69004267D1 (de) | Glycyl-p-amino-pyridin zur behandlung von seniler demenz. | |
| CZ145095A3 (en) | Novel triazoloquinazolines, process of their preparation and use | |
| ATE292970T1 (de) | Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden | |
| UY25369A1 (es) | Procedimiento para preparar inhibidores de proteasa | |
| PT100508A (pt) | Composicoes farmaceuticas e processo para a sua preparacao |